(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -2.39%76.08B | -6.25%49.55B | -3.31%20.45B | -2.37%114.22B | 0.42%77.95B | 5.70%52.86B | -14.89%21.15B | -9.70%116.99B | -16.57%77.62B | -19.61%50.01B |
Special items of operating revenue | 21.13%513.99M | 44.09%314.18M | -1.71%140.38M | -9.17%578.87M | -2.57%424.31M | -22.67%218.04M | 5.96%142.82M | -9.78%637.31M | -10.82%435.49M | -11.56%281.96M |
Operating income | -2.27%76.6B | -6.05%49.87B | -3.30%20.59B | -2.40%114.8B | 0.40%78.37B | 5.54%53.08B | -14.78%21.29B | -9.70%117.62B | -16.54%78.06B | -19.57%50.29B |
Operating expenses | 3.88%-61.89B | 8.26%-40.23B | 5.95%-16.48B | 5.46%-93.12B | 0.64%-64.39B | -5.09%-43.85B | 15.53%-17.52B | 10.92%-98.5B | 16.85%-64.8B | 19.65%-41.72B |
Gross profit | 5.16%14.71B | 4.49%9.64B | 9.00%4.11B | 13.35%21.68B | 5.51%13.99B | 7.70%9.23B | -11.08%3.77B | -2.86%19.13B | -15.01%13.26B | -19.15%8.57B |
Selling expenses | 2.82%-2.05B | 4.48%-1.36B | 10.70%-648.65M | -9.25%-4.21B | 12.41%-2.11B | 9.44%-1.43B | 24.13%-726.41M | 16.25%-3.85B | 31.40%-2.4B | 34.33%-1.57B |
Administrative expenses | -1.66%-5.23B | -0.04%-3.38B | 1.40%-1.63B | 2.11%-8B | 2.10%-5.14B | 1.94%-3.38B | -0.64%-1.65B | -2.99%-8.17B | -4.28%-5.25B | -5.23%-3.45B |
Research and development expenses | -3.30%-3.69B | -0.02%-2.33B | -2.92%-1.01B | -6.78%-5.37B | -10.54%-3.57B | -22.12%-2.33B | -15.20%-985.48M | 6.98%-5.03B | 8.27%-3.23B | 11.13%-1.91B |
Profit from asset sales | -100.28%-973K | -78.14%4.9M | -82.52%4.42M | 51.13%847M | 281.99%342.7M | -70.09%22.4M | -68.45%25.28M | 206.14%560.44M | -34.11%89.72M | -48.56%74.9M |
Revaluation surplus | -732.22%-339.98M | -189.95%-319.89M | -179.11%-249.24M | 55.99%-314.79M | 107.07%53.78M | 321.73%355.64M | 2,181.54%315.04M | -141.93%-715.32M | -211.56%-760.21M | -123.71%-160.4M |
-Changes in the fair value of other assets | -732.22%-339.98M | -189.95%-319.89M | -179.11%-249.24M | 55.99%-314.79M | 107.07%53.78M | 321.73%355.64M | 2,181.54%315.04M | -141.93%-715.32M | -211.56%-760.21M | -123.71%-160.4M |
Impairment and provision | 17.31%-1.26B | 49.23%-801.15M | -96.86%-209.47M | 18.43%-3.46B | 17.87%-1.52B | -8.35%-1.58B | 56.99%-106.41M | 72.68%-4.24B | 80.67%-1.85B | 83.96%-1.46B |
-Other impairment is provision | 17.31%-1.26B | 49.23%-801.15M | -96.86%-209.47M | 18.43%-3.46B | 17.87%-1.52B | -8.35%-1.58B | 56.99%-106.41M | 72.68%-4.24B | 80.67%-1.85B | 83.96%-1.46B |
Operating interest expense | -12.40%-71.02M | -22.16%-50.13M | -33.83%-27.84M | 0.74%-86.52M | -1.37%-63.18M | -36.96%-41.04M | -119.47%-20.8M | 15.57%-87.17M | 11.78%-62.33M | 33.02%-29.96M |
Special items of operating profit | 2.25%2.22B | -10.31%1.44B | 5.46%663.3M | 83.06%4.05B | 41.39%2.17B | 76.09%1.61B | 105.58%628.95M | -21.76%2.21B | -53.92%1.53B | -44.97%914.89M |
Operating profit | 5.45%3.86B | 19.18%2.56B | -22.64%872.27M | 713.35%4.44B | 272.64%3.66B | 188.01%2.15B | 44.45%1.13B | 92.55%-723.41M | 142.05%983.41M | 118.19%745.84M |
Financing cost | 32.92%-478.4M | 30.38%-202.26M | 68.13%-70.29M | 16.84%-1.08B | 29.02%-713.14M | 57.39%-290.52M | 39.56%-220.55M | -15.40%-1.3B | -5.02%-1B | -23.48%-681.8M |
Special items of earning before tax | 380.18%57.66M | 228.73%45.41M | 219.97%5.18M | -222.70%-60.32M | 36.04%-20.58M | -210.26%-35.28M | -213.86%-4.32M | -91.04%49.16M | -118.93%-32.18M | -74.77%32M |
Earning before tax | 17.49%3.44B | 31.88%2.4B | -10.58%807.17M | 266.80%3.29B | 5,584.71%2.93B | 1,797.55%1.82B | 115.22%902.64M | 80.80%-1.98B | 98.29%-53.44M | 102.12%96.03M |
Tax | -71.78%-881.81M | -73.12%-581.58M | -21.19%-253.97M | -237.54%-1.14B | -127.71%-513.35M | -57.28%-335.93M | -103.47%-209.57M | -782.13%-337.71M | 64.96%-225.44M | 48.25%-213.58M |
After-tax profit from continuing operations | 5.96%2.56B | 22.56%1.82B | -20.18%553.2M | 193.17%2.15B | 966.88%2.42B | 1,364.42%1.49B | 119.04%693.07M | 77.41%-2.31B | 92.60%-278.88M | 97.62%-117.55M |
Earning after tax | 5.96%2.56B | 22.56%1.82B | -20.18%553.2M | 193.17%2.15B | 966.88%2.42B | 1,364.42%1.49B | 119.04%693.07M | 77.41%-2.31B | 92.60%-278.88M | 97.62%-117.55M |
Minority profit | 12.97%1.8B | 36.15%1.22B | 59.77%521.19M | 49.17%1.87B | 40.35%1.6B | 2.54%895.98M | 7.39%326.22M | 596.97%1.25B | 74.01%1.14B | 2,572.79%873.79M |
Profit attributable to shareholders | -7.67%758.31M | 1.93%601.74M | -91.27%32.01M | 108.00%285.16M | 157.99%821.27M | 159.55%590.36M | 2,802.32%366.85M | 64.29%-3.57B | 67.98%-1.42B | 80.06%-991.34M |
Basic earnings per share | -7.55%0.049 | 2.63%0.039 | -91.06%0.0021 | 107.89%0.018 | 158.89%0.053 | 163.33%0.038 | 2,837.50%0.0235 | 64.38%-0.228 | 69.10%-0.09 | 81.25%-0.06 |
Diluted earnings per share | -7.55%0.049 | 2.63%0.039 | -91.06%0.0021 | 107.89%0.018 | 158.89%0.053 | 163.33%0.038 | 2,837.50%0.0235 | 64.38%-0.228 | 69.10%-0.09 | 81.25%-0.06 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data